AdvisorShares Psychedelics ETF (PSIL) Dividend Yield, History & Forecast

AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 6.85% ($1.70 per share annually (TTM)). The most recent ex-dividend date was December 22, 2025, with payment scheduled for December 29, 2025. market capitalization is approximately $25M. Review PSIL dividend history on this scorecard, compare peers in the Compare Dividend Returns tool, or project income with the dividend calculator.

PSIL fund composition

PSIL holds 25 positions, with 69.2% of assets in its ten largest. It charges an expense ratio of 1.84%, and manages $57.2M.

Top 10 holdings

HoldingWeight
ATAIATAIBECKLEY INC11.70%
CMPSCOMPASS PATHWAYS PLC10.94%
DFTXDefinium Therapeutics, Inc10.29%
HELPCYBIN INC7.83%
CYBNCYBIN INC5.31%
ANROALTO NEUROSCIENCE INC4.89%
NRXPNRX PHARMACEUTICALS INC4.66%
NBIXNEUROCRINE BIOSCIENCES INC4.57%
GHRSGH RESEARCH PLC4.55%
RLMDRELMADA THERAPEUTICS INC4.43%

Sector allocation

Healthcare100.0%Cash & Others13.8%Consumer Defensive1.7%

Frequently Asked Questions about AdvisorShares Psychedelics ETF (PSIL)

What is AdvisorShares Psychedelics ETF's dividend yield?
AdvisorShares Psychedelics ETF (PSIL) pays a current trailing twelve-month dividend yield of 6.85%, which works out to $1.70 per share annually based on the most recent payout schedule.
When does AdvisorShares Psychedelics ETF pay distributions?
The most recent ex-dividend date was December 22, 2025. The next scheduled dividend payment date is December 29, 2025.
How many years has AdvisorShares Psychedelics ETF increased its dividend?
AdvisorShares Psychedelics ETF (PSIL) has increased its dividend for 2 consecutive years.
What does AdvisorShares Psychedelics ETF invest in?
This actively managed Exchange Traded Fund (ETF) endeavors to meet its investment goals by typically allocating a minimum of 80% of its total net assets (including any capital secured through borrowing for investment purposes) into the securities of specific companies. To be eligible for inclusion, these companies must either derive at least half of their net revenue from, or commit 50% or more of their assets to, psychedelic compounds, their derivatives, or other financial instruments exhibiting similar economic characteristics. The fund's primary holdings consist of publicly traded life...